HMGCS2 and metabolic dysfunction-associated steatohepatitis: Furthermore, we will elucidate the therapeutic potential of cynaroside in ameliorating NASH with T2DM through the regulation of HMGCS2-dependent ketogenesis and explore its underlying molecular mechanisms.